lajollamycin

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namelajollamycin
Drug Alias Nameanti-infective (Nereus)anticancer agent (Nereus)
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasmsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNereus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNereus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A